Nyxoah S.A. (id:391 NYXH)
7.90 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 11/22/2024 1:01:22 AM)
Exchange closed, opens in 7 hours 58 minutes
-1.25 EUR (-1.25%)
-1.99 EUR (-1.99%)
-5.95 EUR (-5.95%)
-4.13 EUR (-4.13%)
69.89 EUR (69.89%)
-60.50 EUR (-60.50%)
About Nyxoah S.A.
Market Capitalization 311.57M
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
| Headquarters (address) |
Rue Edouard Belin 12 Mont-Saint-Guibert 1435 Belgium |
| Phone | 32 10 22 23 55 |
| Website | https://www.nyxoah.com |
| Employees | 146 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Ticker | NYXH |
| Exchange | European Stock Exchange |
| Currency | EUR |
| 52 week range | 3.79 - 17.60 |
| Market Capitalization | 311.57M |
| P/E trailing | -5.07 |
| P/E forward | -4.68 |
| Price/Sale | 61.31 |
| Price/Book | 2.66 |
| Beta | 0.548 |
| EPS | -1.72 |
| EPS Belgium (ID:14, base:79) | 4.64 |